Yasuo Takashima

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Immune Response

Cerebrospinal Fluid

Diffuse Large B Cell Lymphoma

Top Venues

International journal of clinical oncology

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Yasuo Takashima, Momoko Hamano, Kengo Yoshii, Azusa Hayano, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Hiroaki Hondoh, Ryuya Yamanaka
Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma. International journal of clinical oncology 28 (3) (2023)
Yasuo Takashima, Momoko Hamano, Kengo Yoshii, Azusa Hayano, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Hiroaki Hondoh, Ryuya Yamanaka
Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma. International journal of clinical oncology 28 (3) (2023)
Yasuo Takashima, Momoko Hamano, Kengo Yoshii, Azusa Hayano, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Hiroaki Hondoh, Ryuya Yamanaka
Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma. International journal of clinical oncology 28 (3) (2023)
Yasuo Takashima, Momoko Hamano, Kengo Yoshii, Azusa Hayano, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Hiroaki Hondoh, Ryuya Yamanaka
Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma. International journal of clinical oncology (2023)
Yasuo Takashima, Atsushi Kawaguchi, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Hiroaki Hondoh, Ryuya Yamanaka
Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma. PloS one 16 (6) (2021)
Yasuo Takashima, Momoko Hamano, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Tsutomu Kobayashi, Hiroaki Hondoh, Ryuya Yamanaka
GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL. Scientific reports 10 (1) (2020)
Yasuo Takashima, Atsushi Kawaguchi, Yasuo Iwadate, Hiroaki Hondoh, Junya Fukai, Koji Kajiwara, Azusa Hayano, Ryuya Yamanaka
miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma. PloS one 15 (2) (2020)
Yasuo Takashima, Atsushi Kawaguchi, Azusa Hayano, Ryuya Yamanaka
CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme. PloS one 14 (5) (2019)
Azusa Hayano, Yasuo Takashima, Ryuya Yamanaka
Cell-type-specific sensitivity of bortezomib in the methotrexate-resistant primary central nervous system lymphoma cells. International journal of clinical oncology 24 (9) (2019)
Yasuo Takashima, Atsushi Kawaguchi, Ryuya Yamanaka
Promising Prognosis Marker Candidates on the Status of Epithelial-Mesenchymal Transition and Glioma Stem Cells in Glioblastoma. Cells 8 (11) (2019)
Yasuo Takashima, Atsushi Kawaguchi, Yasuo Iwadate, Hiroaki Hondoh, Junya Fukai, Koji Kajiwara, Azusa Hayano, Ryuya Yamanaka
MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma. PloS one 14 (1) (2019)